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There are still many factors to discover to explain the low success rates of islet allografts. In this study, we dem-
onstrate that specific subpopulations of alloreactive NK cells may be involved in the failure of islet allografts. 
By performing allotransplantation in rats (n = 13), we observed peripheral expansion and infiltration of alloreac-
tive Ly49i2+ NK cells in the grafts. An effective strategy in rats to enhance the expansion of Ly49i2+ NK cells 
is performing a rat cytomegalovirus infection (n = 6). Cytomegalovirus infection was associated with an early 
expansion of the Ly49i2+ NK cells and accelerated islet graft failure. The Ly49i2+ NK cells are both alloreactive 
and involved in virus clearance. The expansion of this subpopulation could not be blocked by cyclosporin A 
immunosuppression. Also alloreactive KLRH1+ NK cells infiltrated the grafts, but nonalloreactive NKR-P1B+ 
cells were not observed in the islet allografts. Perforin staining of the infiltrating NK cells demonstrated the cyto-
toxic capacity of these cells. Our data suggest a role for this NK subpopulation in rat islet allograft destruction.
Key words: Islets; Natural killer (NK) cells; Allotransplantation; Immunosuppression; Cytomegalovirus
allograft setting, the role of NK cells is less clear, but as 
current immunosuppressive protocols applied in islet trans-
plantation have no effect on NK cells, it might be an over-
looked factor in the success or failure of islet grafts (18).
An important role for NK cells in allorecognition and 
graft rejection has been demonstrated in bone marrow 
(21,22,30,40) and solid organ transplantation (11,32,37). 
NK cells can be found in different subpopulations with 
distinct functions. In rodents, these NK cell subpopula-
tions can be identified based on the differential expres-
sion of major histocompatibility complex I (MHC class 
I) recognizing killer cell lectin-like receptors (KLRs). 
Several KLR families are clustered together within the 
NK cell complex (NKC) and contain both inhibitory 
and activating family members. NK cells expressing 
a combination of the inhibitory Ly49i2, the activating 
Ly49s3, and the inhibitory KLR subfamily H, member 
1 (KLRH1) are, in vitro, highly alloreactive toward allo-
geneic target cells expressing foreign MHC class I mol-
ecules (34–36). A functionally distinct population of rat 
NK cells expresses natural killer cell surface protein P1B 
(NKR-P1B), a receptor distinct from Ly49 receptors (25). 
INTRODUCTION
Large-scale clinical application of islet transplanta-
tion is hampered by a low long-term success rate. With 
the present approaches, only approximately 10% of the 
recipients are still normoglycemic and insulin indepen-
dent at 5 years after transplantation (39). To improve 
long-term graft survival, it is important to identify the 
factors involved in success or failure of islet allografts.
In a recent rat study, we found high numbers of natural 
killer (NK) cells in failing rat islet allografts (42). This 
NK cell infiltration was enhanced after cytomegalovirus 
(CMV) infection. NK cells have not received much atten-
tion in islet allograft failure but have been suggested to 
be a factor involved in failure of human islets in the liver 
(23). A recent report shows this may not be restricted to 
the liver as both human and rodent islets carry the recep-
tor for NK cell p46-related protein (NKp46), an NK cell 
receptor that after ligation recognizes pancreatic b-cells 
(18). In the autoimmune process leading to type 1 dia-
betes, evidence is accumulating that NK cells and nat-
ural killer T (NKT) cells play an important role in the 
destruction of b-cells (5,18). For destruction of b-cells in an 
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These NKR-P1B-positive NK cells effectively lyse tumor 
target cells but fail to recognize allogeneic targets (25). It 
is unknown whether these subpopulations are involved 
in islet allograft rejection.
In the present study, we hypothesized that islet allograft 
failure is associated with selective expansion of alloreac-
tive Ly49/KLRH1-expressing NK cell subpopulations and 
that this population can be enhanced by CMV. To test the 
hypothesis, we applied two approaches. First, we applied 
a rat allograft transplantation model in which immuno-
suppression was withdrawn after 10 days to allow gradual 
development of an allograft response to follow the kinet-
ics of NK cell recruitment in the circulation. Second, we 
performed an infection with CMV in the rat recipient of 
islet allografts at 1 day after implantation. CMV is known 
to enhance alloreactivity against rodent islets (42) and is 
recognized for the effects on NK cells (1,12,38). We stud-
ied the association of recruitment of Ly49+ NK cells and 
survival of islet allografts. The NK cell subpopulations 
that are responsive to CMV are unknown. We studied, 
in both experiments, the Ly49i2-, Ly49s3-, KLRH1-, and 
NKR-P1B-expressing NK cell subpopulations, before 
and after the withdrawal of immunosuppression.
MATERIALS AND METHODS
Study Design
Streptozotocin (STZ)-treated diabetic male Albino 
Oxford (AO; u-u-u haplotype) rats received a renal sub-
capsular male Lewis (l-l-l haplotype) rat islet graft. AO rats 
are known to be high NK cell responders (26). Cyclosporin 
A (CsA) immunosuppression was applied but was with-
drawn at 10 days after implantation. To study NK cell (sub)
populations, blood was sampled from the tail vein 1 day 
before transplantation (Pre-Tx) and at days 7 and 13 after 
implantation, and just before graft failure. After sacrifice, 
the islet grafts were retrieved. Islet grafts were sectioned 
and stained to study infiltrating NK cell subpopulations. 
One day after transplantation, six AO rat islet graft recipi-
ents received a CMV infection, while seven of the recipi-
ents received a mock infection and served as controls. 
CMV-infected and mock-infected rats were transplanted 
pairwise or in triplicate (two CMV-infected recipients vs. 
one mock-infected control) to reduce batch-to-batch dif-
ferences in islet quality as much as possible. All CMV-
infected animals and three mock-infected controls were 
sacrificed after complete graft failure. Four paired mock-
infected control animals were sacrificed after graft failure 
of the corresponding CMV-infected recipient.
Experimental Animals and Diabetes Induction
Inbred male AO rats (u-u-u, Harlan, Oss, the 
Netherlands) weighing 280–300 g served as islet recipients. 
As islet donors, inbred male Lewis rats (l-l-l) (Harlan) 
weighing 300–320 g were used. All animal experiments 
were performed after receiving approval of the Institutional 
Animal Care Committee of the Groningen University.
Diabetes was induced in the recipient rats by injection of 
75 mg/kg streptozotocin (Zonasar, Upjohn Co., Kalamazoo, 
MI, USA) via the tail vein. Only animals showing weight 
loss and two consecutive blood glucose measurements 
exceeding 20 mmol/L served as islet graft recipients.
Islet Isolation and Transplantation
Islets were isolated from pancreata of Lewis rats as 
previously described (7). The total islet volume obtained 
by the isolation procedure was determined by measuring 
the diameters of the islets in a 2% aliquot of the islet sus-
pension (9).
Transplantation of 5-μl islet grafts under the kidney cap-
sule was performed immediately after the islet isolation 
procedure under isoflurane anesthesia. The transplanted 
endocrine graft volume of 5 μl induces normoglycemia in 
100% of noninfected recipients (48). Immunosuppression 
was applied for 10 days. For this, rats received 5 mg/kg 
cyclosporin A (CsA; Sandimmune, Novartis, Basel, 
Switzerland) subcutaneously on a daily basis, starting at 
the day of transplantation (42).
CMV Infection
Rats received a rat CMV (RCMV) infection by intra-
peritoneal injection of 2 × 105 plaque-forming units (pfus) 
of RCMV (Maastricht strain) at day 1 after islet transplan-
tation isolated as previously described (4). The amount 
of infectious virus was determined by plaque assay (4). 
Virus-free homogenate was obtained by homogenization 
of salivary glands of irradiated, noninfected AO rats. This 
virus-free homogenate was injected as control and called a 
mock infection. Mock infection was established by intrap-
eritoneal injection of virus-free salivary gland homogenate 
at day 1 after transplantation.
Graft Function and Sacrifice
The glucose concentration was determined using the 
Accu-Chek Sensor system (Roche, Mannheim, Germany). 
Transplantation was considered successful when nonfast-
ing blood glucose concentrations reached levels below 
10 mmol/L. Animals were sacrificed when animals dem-
onstrated two blood glucose measurements exceeding 
20 mmol/L in a period of 1 week.
After graft failure, pancreas, kidneys, salivary glands, 
spleens, and islet grafts were removed for histological 
examination. Islet grafts were removed and snap frozen 
in liquid nitrogen. Grafts were sectioned at 5 μm and 
stored at −20°C until use.
Detection of Viral Infection
To confirm successful viral infection in the salivary 
glands, we performed PCR analysis for viral DNA and 
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did histological staining for RCMV early protein R44 as 
described below. All RCMV-infected animals had viral 
DNA and R44-positive cells within the salivary glands, 
showing successful systemic CMV infection.
RCMV PCR
To determine the presence of viral DNA in the sali-
vary glands, DNA was extracted by lysing the tissue in 
SE buffer containing 75 mM NaCl, 25 mM ethylenedi-
aminetetraacetic acid (EDTA), 1% sodium dodecyl sul-
fate (SDS) (all from Merck, Darmstadt Germany), and 
200 μg/ml Proteinase K (Life Technologies, Bleiswijk, the 
Netherlands) at 55°C until all tissue was dissolved. DNA 
was extracted using chloroform–isopropanol extrac tion 
(Sigma-Aldrich). Subsequently, RCMV-specific (nested) 
PCR analysis was performed as described previously (3).
The forward primer sequence was 5¢-AAGGGATC
CGATTTCGCCAGCCTCTACC-3¢, the reverse primer 
sequence was 5¢-AAGGGATCCTGTCGGTGTCCCCG
TACAC-3¢. The nested forward primer sequence was 5¢- 
AAGGGATCCCCTCTGTTACTCCACCCTGC-3¢, the 
nested reverse primer sequence was 5¢-TTCGGATCCA
CGCCGACCTCGGAGACCAG-3¢. DNA from RCMV-
infected rat embryonic fibroblasts served as a positive 
control. When samples were negative after the first-round 
PCR, we performed nested PCR. PCR products were 
visualized by ethidium bromide staining (Sigma-Aldrich, 
Zwijndrecht, the Netherlands) and agarose gel electro-
phoresis (Invitrogen/Life Technologies).
Detection of R44 Protein
The salivary glands were removed after the animals 
were sacrificed and snap frozen in liquid nitrogen. The 
salivary glands were sectioned at 5 μm, 10 min fixed in 
ice-cold acetone (Sigma-Aldrich), and air dried for histo-
logical examination. Endogenous peroxidase was blocked 
for 20 min in phosphate-buffered saline (PBS; Sigma-
Aldrich) containing 0.15% hydrogen peroxide (Merck). 
Sections were incubated with mAb8 (1:8) (24) directed 
against RCMV R44 for 1 h. Subsequently, sections were 
incubated with horseradish peroxidase-conjugated rabbit 
anti-mouse IgG1 (Dako, Glostrup, Denmark) for 30 min. 
The whole procedure was performed at room tempera-
ture. Peroxidase activity was demonstrated by using 3,3¢-
diaminobenzidine tetra HCL (Sigma-Aldrich) containing 
hydrogen peroxide. In all control sections, PBS was used 
instead of the primary antibody. All control sections were 
consistently negative.
Flow Cytometry
Flow cytometry was performed on blood and sple-
nocytes. Blood was collected at regular time intervals 
from the tail vein. A sample of 40 μl of blood was applied 
to count the total number of leukocytes per milliliter 
of blood or splenocytes, using the Coulter Counter Z1 
(Coulter, Hialeah, FL, USA). The remainder of the blood 
was diluted 1:1 with PBS and centrifuged for 20 min at 
1,200 × g at 4°C. Buffy coats were taken out, and erythro-
cytes were lysed using NH4Cl (Sigma-Aldrich) for 10 min 
at 4°C. After centrifugation (1,200 × g for 10 min at 4°C), 
leukocytes were resuspended in PBS containing 5% fetal 
calf serum (FCS; Gibco, Bleiswijk, the Netherlands) and 
0.1% sodium azide (Sigma-Aldrich) and counted.
Splenocytes were isolated from the spleen according 
to standard methods (43) and were collected on the day of 
sacrifice. After washing, the erythrocytes were lysed using 
NH4Cl for 10 min at 4°C. After centrifugation (1,200 × g 
for 10 min at 4°C), splenocytes were resuspended in PBS 
containing 5% FCS and 0.1% sodium azide and counted.
For three-color flow cytometric analysis, 5 × 105 cells 
(blood or splenocytes) were resuspended in PBS contain-
ing 5% FCS and 0.1% sodium azide (PBS/FCS/azide). 
All antibodies were obtained from BD Pharmingen (San 
Diego, CA, USA) unless otherwise specified. Primary 
antibodies used were peridinin chlorophyll (PerCP)-
conjugated R73 (1:100) against rat T-cell receptor (TCR) 
ab (cluster of differentiation 3; CD3), combined with 
phycoerythrin (PE)-conjugated anti-NKR-P1A (1:50), 
and combined with either biotin-conjugated STOK2 
(1:100) against Ly49i2 (34), biotin-conjugated STOK6 
(1:50) against Ly49s3 (26), biotin-conjugated DAR13 
(1:100) against Ly49s3 (35), biotin-conjugated STOK9 
(1:300) against KLRH1 (36), or biotin-conjugated 
STOK27 (1:100) against NKR-P1B (25). STOK6 and 
DAR13 (kind gifts of Dr. Vaage, Institute of Immunology, 
Rikshospitalet University Hospital, Oslo, Norway) both 
recognize Ly49s3 on AO NK cells (26). Blood NK cells 
were stained with STOK6 antibody. Splenocytes were 
stained with both STOK6 and DAR13. Similar percent-
ages of NK cells positive for DAR13 and STOK6 con-
firmed that both antibodies recognize the same receptor. 
After washing in PBS/FCS/azide, allophycocyanine 
(APC)-conjugated streptavidin was added for 30 min. 
Cells were washed twice and resuspended in PBS/FCS/
azide and analyzed by flow cytometry (FACS Calibur, 
Beckton Dickinson, San Jose, CA, USA). During flow 
cytometry, we counted at least 5 × 104 lymphocytes, based 
on the forward and sidescatter pattern. Data were ana-
lyzed using Winlist 5.0 software (Verity Software House, 
Topsham, ME, USA). During analysis, lymphocytes 
were gated in the forward-sidescatter plot (Fig. 1A). This 
gate was then copied to a PerCP (TCR)-PE (NKR-P1A) 
plot (Fig. 1B), and NKR-P1A-positive/TCR-negative 
cells were defined as NK cells. A sample stained for 
NKR-P1A, TCR, and only streptavidin-APC was used 
to set the gate so that 99% of the cells were negative 
(Fig. 2A, control). This gate was then copied to the sam-
ples stained for and the percentage of cells positive for 
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Ly49i2, Ly49s3, KLRH1, and NKRP1B was determined 
within the NK cell population (Fig. 2B). Absolute cell 
numbers were calculated by multiplying percentages by 
the number of white blood cells.
Fluorescence Microscopy
Grafts were retrieved, snap frozen, sectioned, and 
stained for the presence of cells expressing NKR-P1A, 
NKp46 (41), and Ly49i2, Ly49s3, KLRH1, NKR-P1B, 
and perforin (all BD).
In short, islet graft sections were air dried and fixed 
in ice-cold acetone before starting the staining procedure. 
Endogenous avidin and biotin were blocked using a two-
step avidin–biotin block kit (Dako). Primary antibodies 
were incubated for 1 h, and secondary antibodies were 
incubated for 30 min. The whole procedure was performed 
at room temperature in the dark. Primary monoclonal anti-
bodies used were anti-NKR-P1A (1:50) and WEN23 (1:100) 
(kind gift from Erik Dissen, Rikshospitalet, Oslo, Norway) 
directed against NKp46, goat anti-perforin (1:50; Santa Cruz 
Biotechnologies, Santa Cruz, CA, USA), biotin-conjugated 
STOK2 (1:100) against Ly49i2, biotin-conjugated DAR13 
(1:100) against Ly49s3, biotin-conjugated STOK9 (1:300) 
against KLRH1, and biotin-conjugated STOK27 (1:100) 
against NKR-P1B. Secondary antibodies used were goat 
anti-mouse-tetrarhodamine isothiocyanate (TRITC; 1:50; 
Dako) and goat anti-mouse biotin (1:100; Dako). Cy3-
conjugated streptavidin (1:100) was used to determine the 
presence of NKp46-positive cells, and FITC-conjugated 
streptavidin (1:100) to determine the presence of Ly49/
KLRH1-positive cells.
Finally, sections were counterstained with 2 μg/ml 
4¢,6-diamidino-2-phenylindole (DAPI; Molecular Probes, 
Eugene, OR, USA), mounted in Citifluor (Sigma-Aldrich), 
and analyzed by fluorescence microscopy (Leica Micro-
systems, Buffalo Grove, IL, USA). In all control sections, 
PBS was used instead of the primary antibodies. All con-
trol sections were consistently negative.
Quantification of infiltrating NK cell subpopulations 
was assessed using a similar scoring system to those pre-
viously described (8,47). Five randomly selected techni-
cians were asked to blindly score a large panel of stained 
graft sections of infected and noninfected animals on a 
semiquantitative scale. From these results, an average 
infiltration score was determined for the CMV-infected 
and MOCK-infected animals and tested for statistical 
significance. All sections were viewed first and subse-
quently graded, using a semiquantitative scoring system 
with five grades: 0, no positive cells, to 4, large amounts 
of positive cells.
Statistics
Values are expressed as mean ± standard error of the 
mean (SEM) except where nonparametric, in which case 
median (range) was used. Normal distribution of the data 
was confirmed using the Kolmogorov–Smirnov test. 
Statistical comparisons were performed using the one-
way ANOVA, subsequently followed by the two-sided 
Dunnett post hoc test that corrects for multiple compari-
sons (blood) or the two-sided Student’s t test (spleen). 
Where no normal distribution could be demonstrated, 
we applied the nonparametric Mann–Whitney U test. 
Values of p < 0.05 were considered to be statistically 
significant.
RESULTS
Islet Allograft Failure Is Associated With the 
Recruitment of Cytotoxic, Allogeneic NK Cells
All recipients of an islet allograft became normoglyce-
mic within 7 days after transplantation. After 10 days of 
complete immunosuppression, CsA was withdrawn, after 
which the allogeneic response developed. Graft failure 
Figure 1. Gating strategy for the natural killer (NK) cells. Lymphocytes were gated in the forward sidescatter plot (A). This gate 
was then copied to a peridinin chlorophyll (T-cell receptor)–phycoerythrin (natural killer cell surface protein P1A) (PerCP [TCR]-PE 
[NKR-P1A]) plot (B), and NKR-P1A-positive/TCR-negative cells were defined as NK cells.
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was complete at 27.3 ± 0.3 days. The composition of the 
NK cell population in blood was studied 1 day before 
(Pre-Tx), at day 7, at day 13 (i.e., 3 days after stopping the 
administration of CsA), and after the allogeneic response 
(i.e., at the day of complete graft failure).
The frequency of NK cells and NK cell subpopula-
tions was determined in the blood of allogenically trans-
planted rats by flow cytometry (Fig. 2A). The size of the 
total NK cell population in the blood did not significantly 
change (Fig. 2B), but there were clear differences in the 
subpopulations of circulating NK cells. The proportion 
of allogeneic NK cells expressing Ly49i2 increased pre-
ceding graft failure (day 13: p < 0.01), which returned, as 
expected, to baseline levels after complete rejection of the 
graft (day 27: p < 0.05) (Fig. 2B). Significant changes in 
the proportion of NK cells expressing Ly49s3, KLRH1, 
or NKR-P1B were not observed (Fig. 2B).
In the four mock-infected, control grafts that were 
sacrificed at the moment of graft failure of their CMV-
infected counterpart, we found high numbers of NK cells. 
They scored a median of 2.5 (range 2–3) for infiltration. 
Large numbers of both NKR-P1A+ (Fig. 3A) as well as 
NKp46+ cells (Fig. 3B) were found in the islet allografts 
[median 2.5 (range 2–3)]. NKp46 is a cytotoxicity recep-
tor solely expressed on NK cells (27,28).
To confirm the cytotoxic potential of these cells, we 
performed double stainings for NKp46 and perforin (2). 
Infiltrating NK cells contained perforin granules (Fig. 3C, 
yellow arrows). Notably, infiltration of perforin-negative 
NK cells was also observed (Fig. 3C, red cells), suggest-
ing that also noncytotoxic NK cells infiltrated the islet 
grafts.
Since NK cell alloreactivity can be attributed to spe-
cific subpopulations rather than the NK cell population 
as a whole, we determined the infiltration of allorespon-
sive NK cells expressing Ly49i2, Ly49s3, and KLRH1 
(25,26,34–36), and nonalloresponsive NK cells express-
ing NKR-P1B (25). This was done by performing double 
staining for the NK cell marker NKR-P1A combined 
with antibodies directed against inhibitory Ly49i2, acti-
vating Ly49s3, and inhibitory KLRH1, as well as anti-
bodies against NKR-P1B. Double staining using NKp46 
Figure 3. Cytotoxic NK cells in islet allografts from mock-infected rats on day 13 posttransplantation. Retrieved islet allografts were 
stained for the presence of NKR-P1A (A) and natural killer cell p46-related protein (NKp46) (B) positive cells (magnification: 20×). 
NKp46 (red) and perforin (green) staining demonstrates the presence of cytotoxic NK cells in the islet allografts (magnification: 40×) 
(C). Arrows show perforin-positive NK cells (i.e., double positive cells).
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were not possible, since all antibodies required streptavi-
din conjugates.
The infiltration of specific alloreactive NK cell sub-
populations was demonstrated by the presence of allore-
active Ly49i2+ (Fig. 4A), Ly49s3+ (Fig. 4B), and KLRH1+ 
(Fig. 4C), but not the nonalloresponsive NKR-P1B+ NK 
cells in the islet allografts (data not shown).
CMV Promotes the Recruitment of Cytotoxic NK Cells 
and Is Associated With Accelerated Islet Graft Failure
All recipients became normoglycemic within 7 days. 
The CMV-infected rats, however, showed complete graft 
failure 10.6 ± 1.0 days after transplantation, which was 
significantly faster than that in the mock-infected control 
animals (23.2 ± 1.4 days; p < 0.05).
We observed an increased number of NK cells in 
the blood of CMV-infected recipients compared to the 
 mock-infected controls (p < 0.001) (Fig. 5A). This eleva-
tion was already observed as soon as 7 days after implanta-
tion (i.e., under complete CsA immunosuppression). CMV 
infection induced an increased proportion of Ly49i2+ 
NK cells (day 7: p < 0.05). The proportion of Ly49i2+ 
NK cells was further increased on the day of graft fail-
ure (day 13 vs. pre-Tx: p < 0.05). In addition, 7 days 
Figure 4. NK cell subpopulations in islet allografts from mock-infected control rats on day 13 posttransplant. Retrieved islet allografts 
were stained for the presence of NKR-P1A (red) and Ly49i2 (A), Ly49s3 (B), or KLRH1 (C) (all green) positive cells. Double positive 
cells are depicted by the yellow arrows.
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after transplantation, the proportion of Ly49s3+ NK cells 
almost doubled in CMV-infected recipients (day 7 vs. 
pre-Tx and CMV vs. mock-infected control; p < 0.05). 
Significant changes in the KLRH1+ or NKR-P1B+ NK 
cell population were not observed. Thus, preceding islet 
graft failure, CMV-infected allograft recipients demon-
strated an altered composition of the peripheral NK cell 
population, which is characterized by skewing toward 
alloresponsive Ly49i2+ and Ly49s3+ NK cells.
The total numbers of splenic NK cells were not 
increased when compared to mock-infected controls. Just 
as observed in blood, the splenic NK cells demonstrate 
skewing toward alloreactive Ly49s3+ NK cell subpopula-
tions in response to CMV infection (p < 0.001) (Fig. 5B). 
In the spleen, the percentage of Ly49i2+ NK cells was 
not different between the CMV-infected recipients and 
mock-infected controls. In contrast to peripheral blood 
NK cells, the frequency of KLRH1+ (p < 0.05) and NKR-
P1B+ (p < 0.05) NK cells was decreased in CMV-infected 
recipients compared to the mock-infected controls.
In the grafts, we found high numbers of infiltrating 
NK cells, as illustrated by both the expression of NKR-
P1A (Fig. 6A) (median 3.5; range 3–4), as well as NKp46 
(Fig. 6B) (median 3.5; range 3–4). We stained the tissue 
sections of the islet allografts of CMV-infected recipi-
ents for NK cells expressing Ly49i2, Ly49s3, KLRH1, 
or NKR-P1B. Similar to the islet grafts of noninfected 
recipients, NK cells expressing Ly49i2 (Fig. 7A), Ly49s3 
(Fig. 7B), and KLRH1 (Fig. 7C), but not NKR-P1B 
(not shown), were detected in the islet grafts. Notably, 
the infiltration of both allogeneic Ly49i2- and Ly49s3-
expressing NK cells was increased in the islet grafts of 
CMV-infected recipients compared to the mock-infected 
control animals (Table 1).
DISCUSSION
In the present study, we show that during the process 
of islet allograft failure, islet allografts are infiltrated by 
Ly49/KLRH1+ NK cells. When islet transplantation was 
combined with CMV infection, we observed an associa-
tion between the expansion of circulating Ly49i2+ and 
Ly49s3+ NK cells and islet graft failure. The absence of 
expansion or infiltration of NKR-P1B+ NK cells suggests 
that alloreactive NK cell responses are mediated by spe-
cific Ly49+ or KLRH1+ subpopulations, rather than by the 
NK cell population as a whole.
The infiltration of large numbers of NKR-P1A and 
NKp46-positive cells into the allografts demonstrates 
that the infiltrating Ly49+ and KLRH1+ cells are NK cells 
and not NKT cells. Furthermore, the infiltration of perfo-
rin-containing NK cells demonstrates that the infiltrating 
Ly49/KLRH1+ NK cells are involved in proinflammatory, 
rejection-inducing responses (2), rather than tolerance-
inducing responses (19,28,29). However, the presence of 
perforin-negative NK cells in the islet allografts suggests 
that also other NK effector functions, such as proinflam-
matory cytokine production as shown in our previous 
studies (42,43) and others (32,33), may contribute to islet 
graft failure. We observed increased frequencies in the 
blood and in the spleen together with increased frequen-
cies in the graft in the CMV-infected animals compared 
to the mock-infected controls. This suggests that these 
subpopulations respond to the infection and the allograft 
and contribute to graft failure.
Many in vitro studies demonstrate the high alloreac-
tive potential of rat Ly49+ NK cells (25,35,36), but up 
until now, in vivo studies never focused specifically on 
Ly49+ NK cell subpopulations. It has been shown in 
mice, however, that murine Ly49-expressing NK cell 
Figure 6. NK cells in rat islet allografts of CMV-infected recipients at graft failure on day 13 posttransplantation. Retrieved islet allo-
grafts of CMV-infected recipients were stained for the presence of NKR-P1A (A) and NKp46 (B) positive cells (magnification: 20×).
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subpopulations are alloresponsive in allogeneic bone 
marrow rejection (14,15), solid organ rejection (32), and 
in graft-versus-host disease (GVHD) (31). As Ly49+ NK 
cell populations are not suppressed by immunosuppres-
sion, we feel that our data show that it is advisable to 
study its role in human islet graft failure.
It might be argued that the role of T-cells should be 
studied in addition to that of NK cells. However, T-cells 
have been studied in great detail already (42). Owing to 
constraint in blood supply and experimental materials, 
we focused, in this study, on NK cells as their influence 
Figure 7. NK cell subpopulations infiltrating rat islet allografts of CMV-infected recipients on day 13 posttransplantation. Retrieved 
islet allografts of CMV-infected recipients were stained for the presence of NKR-P1A (red) and Ly49i2 (A), Ly49s3 (B), or KLRH1 
(C) (all green) positive cells. Double positive cells are depicted by the yellow arrows.





Median (Range) p Value
Ly49i2 2 (1–2) 3 (3–4) 0.0498 (*)
Ly49s3 1 (1–2) 3.5 (2.5–4) 0.0498 (*)
KLRH1 2 (2–2.5) 3 (2.5–3) 0.07
All sections were viewed first and subsequently graded using a semi-
quantitative scoring system with five grades: 0, no positive cells, to 4, 
large amounts of positive cells. CMV infection enhanced the influx of 
Ly49 inhibitory 2 (Ly49i2) and ly49 stimulatory 3 (Ly49s3) NK cells in 
the graft, while the presence of killer cell lectin-like receptor subfamily 
H, member 1 (KLRH1) NK cells was not significantly altered.
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on the outcome of islet grafts has not been characterized. 
The Ly49s3+ NK cells are probably the NK cells that are 
directly responsible for allograft failure. This subpopula-
tion has been shown to have allogeneic responsiveness in 
vitro (26) and in bone marrow rejection in vivo (14,15). 
Ly49s3+ NK cells are highly dependent on activating 
Ly49 receptors, rather than on inhibitory Ly49 receptors. 
Moreover, islets are known to upregulate the expression 
of stress-related, nonclassical MHC I ligands for activat-
ing NK cell receptors after isolation and transplantation 
(18,20). Taken together, infiltration of Ly49s3+ NK cells 
suggests that besides lack of RT-1A (classical MHC class 
I molecule)-mediated inhibition to NK receptors, activa-
tion of NK cells via nonclassical MHC IB (RT-1CE/N/
M)-Ly49s3 interactions may be of particular importance 
to islet allograft recognition and destruction.
Also, it may be argued that graft failure may be accel-
erated by direct infection of islet cells. However, in a pre-
vious study, we showed that in both rat islets (44) and 
human islets (43), CMV infects a small portion of not 
more than 5% of the cells. This infection degree can-
not explain graft failure. However all islet cells in the 
graft had enhanced expression of proinflammatory mol-
ecules such as MHC-I, intercellular adhesion molecule-1 
(ICAM-1), and lymphocyte function-associated antigen 
3 (LFA-3). This was caused by enhanced secretion of 
interleukin 6 (IL-6), IL-8, IL-15, and monocyte chemo-
tactic protein 1 (MCP-1) by the CMV-infected islet cells 
(43). We therefore concluded that islets have an enhanced 
immunogenicity after CMV infection.
The expansion of the Ly49i2 subpopulation is some-
thing we did not expect. The Ly49i2 is a nonfunctional 
receptor in AO rats (34). Therefore, the responses in 
the Ly49i2+ NK population can only be interpreted as 
an innocent bystander effect. Since Ly49 receptors are 
expressed on overlapping subpopulations (26,35), the 
Ly49i2 response is most likely the result of NK cell acti-
vation through an unidentified Ly49 receptor, enriched 
within the Ly49i2+ NK cell population. The Ly49i2+ NK 
cell infiltration may also be responsible for the infiltra-
tion of KLRH1+ NK cells. Although KLRH1 is expressed 
on highly alloreactive NK cells, the direct involvement of 
KLRH1 in alloreactivity seems unlikely, since alloreactiv-
ity in vitro is not directly mediated through KLRH1, but 
through coexpressed Ly49 receptors (36). Therefore, also 
the infiltration of KLRH1+ NK cells in the islet allografts 
is most likely an innocent bystander response and a direct 
consequence of infiltration of Ly49-expressing alloreac-
tive NK cells.
CMV enhanced the infiltration of Ly49i2+ and Ly49s3+ 
NK cells and was associated with shorter graft survival 
times. This is expected, as after CMV infection, splenic 
antiviral NK cell responses are induced for the clearance 
of virally infected cells and restraining viral spread (27). 
Although we did not observe an expansion of the total 
splenic NK cell compartment after CMV infection, we 
observed an increased proportion of Ly49s3+ NK cells in 
the graft after CMV infection. Several lines of evidence 
point to the involvement of specific NK cell subpopula-
tions in the restraint of CMV. In human renal graft recipi-
ents, the degree of CMV infection is inversely correlated 
to the number of activating killer cell Ig-like receptors 
(KIR) expressed (46). In mice, the activating receptor 
Ly49H is known to recognize m157, a MCMV protein, 
and protects the mice from the early stages of MCMV 
infection (45). It is not known whether Ly49s3 can rec-
ognize RCMV, but it could explain the infiltration of 
Ly49s3+ NK cells in the CMV-infected recipients.
The CMV-induced selective infiltration of highly 
allogeneic Ly49s3+ effector NK cells may explain the 
enhanced alloreactivity after CMV infection that we 
observed in a previous study (42) and in the present study. 
We found that the expansion is splenic and not only local. 
Splenic NK cells serve as a reservoir of mature effector 
NK cells, which are rapidly recruited to sites of inflam-
mation, such as the site of transplantation (16). Although 
NK cells can be activated locally, without the need for 
activation in secondary lymphoid organs, the peripheral 
activation of NK cells enhances NK cell proliferation, 
cytolytic capacities, and cytokine production (6,10,16). 
In this way, CMV infection may simultaneously enhance 
both antiviral and allogeneic NK cells that allow alloge-
neic interactions and exacerbation of allograft rejection.
The present study confirms our hypothesis that islet 
allograft failure is associated with selective expansion 
of alloreactive Ly49/KLRH1+ NK-cell subpopulations. 
These cells infiltrated the grafts. Enhancement of the 
allogeneic subpopulations by CMV infection resulted 
in accelerated islet allograft failure. Depletion of this 
population has been considered but is lethal in rats when 
combined with immunosuppression and CMV. In spite of 
this limitation, our current approach of applying CMV to 
enhance, instead of delete, the population gives us mech-
anistic insight. The mechanism is probably as follows: 
peripheral and local activation of Ly49/KLRH1+ NK cells 
by allogeneic components can efficiently induce expan-
sion of NK cell effector functions by sensing the lack of 
“self” MHC I ligands for the inhibitory receptors and/or 
the presence of MHC I ligands for activating Ly49 recep-
tors. This may lead to graft destruction (Fig. 8A). CMV 
infection was associated with an even more pronounced 
infiltration by Ly49/KLRH1+ NK cells and accelerated 
allograft rejection. This effect of CMV infection may be 
caused by two processes. First, CMV infection favors the 
peripheral expansion of Ly49s3+ NK cells in addition to 
Ly49i2+ NK cells, which not only restrains CMV infec-
tions, but also enhances NK cell effector functions and 
NK cell interactions with allogeneic target cells. Second, 
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since CMV infection is able to induce MHC complex class 
I chain-related gene A or B (MICA or MICB) expression 
on infected human cells (17), a CMV-driven enhanced 
expression of Ly49s3 ligands, that is, either RT-1CE/N/M 
proteins or viral proteins directly (45) may enhance graft 
allogenicity and NK–target cell interactions, subsequently 
leading to graft destruction (Figure 8B).
The findings from the present study may have impli-
cations for human islet transplantation. The currently 
applied immunosuppressives are unable to suppress 
NK cell function (49) or might even enhance NK cell 
cytotoxicity (50). Therefore, also in humans, we feel the 
role of KIR-expressing NK cell subpopulations in islet 
graft failure needs further attention. The same goes for 
the role of CMV in islet graft failure. Although the role of 
CMV is clinically still a subject of debate (13), our data 
warrant caution in interpretation of the effects of CMV 
as we show that it can have unexpected effects on cell 
populations involved in allogeneic responses.
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Figure 8. Contribution of Ly49+ NK cells to islet allograft failure. Ischemia and surgical stress may lead to production of proinflam-
matory factors and the upregulation of nonclassical MHC I molecules in the islet graft. Subsequently, peripheral (via dendritic cells; 
DCs) and local allogeneic NK cell activation may occur due to production of proinflammatory cytokines and lack of inhibitory “self” 
MHC I molecules and/or the expression of activating nonclassical MHC I molecules on islet allografts. Activation of NK effector 
functions may directly lead to cytotoxicity toward the allograft and/or abundant production of proinflammatory cytokines, further 
exacerbating inflammation (A). CMV infection may accelerate the rejection process by increasing the stress-induced release of proin-
flammatory factors and nonclassical MHC I molecules on the islet graft, and stimulating the peripheral expansion of allogeneic NK cell 
subpopulations in the spleen. Increased numbers of circulating alloresponsive NK cells, combined with enhanced inflammation in the 
islet allograft may lead to increased NK cell attraction and infiltration, and accelerated islet allograft destruction (B). RT-1A = classical 
MHC class I molecule; RT-1CE/N/M = nonclassical MHC class IB molecule.
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